A novel tauopathy model mimicking molecular and spatial aspects of human tau pathology
- PMID: 39420962
- PMCID: PMC11483584
- DOI: 10.1093/braincomms/fcae326
A novel tauopathy model mimicking molecular and spatial aspects of human tau pathology
Abstract
Creating a mouse model that recapitulates human tau pathology is essential for developing strategies to intervene in tau-induced neurodegeneration. However, mimicking the pathological features seen in human pathology often involves a trade-off with artificial effects such as unexpected gene insertion and neurotoxicity from the expression system. To overcome these issues, we developed the rTKhomo mouse model by combining a transgenic CaMKII-tTA system with a P301L mutated 1N4R human tau knock-in at the Rosa26 locus with a C57BL/6J background. This model closely mimics human tau pathology, particularly in the hippocampal CA1 region, showing age-dependent tau accumulation, neuronal loss and neuroinflammation. Notably, whole-brain 3D staining and light-sheet microscopy revealed a spatial gradient of tau deposition from the entorhinal cortex to the hippocampus, similar to the spatial distribution of Braak neurofibrillary tangle staging. Furthermore, [18F]PM-PBB3 positron emission tomography imaging enabled the quantification and live monitoring of tau deposition. The rTKhomo mouse model shows potential as a promising next-generation preclinical tool for exploring the mechanisms of tauopathy and for developing interventions targeting the spatial progression of tau pathology.
Keywords: model mouse; tau pathology; tauopathy; tissue clearing; whole brain.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.
Conflict of interest statement
M.H. hold patents on compound related to the present report (JP5422782/EP12884742.3/CA2894994/HK1208672). H.R.U. is a founder of CUBICStars, Inc. that offers services based on CUBIC technology. E.A.S. is employed by the company. E.A.S. and H.R.U. are co-inventors on patents and patent applications owned by RIKEN and CUBICStars, Inc., covering the CUBIC reagents and CUBIC-HV kits, respectively.
Figures







References
-
- Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci. 2001;24:1121–1159. - PubMed
-
- Lewis J, McGowan E, Rockwood J, et al. . Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet. 2000;25(4):402–405. - PubMed
-
- Gotz J, Chen F, Barmettler R, Nitsch RM. Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem. 2001;276(1):529–534. - PubMed
LinkOut - more resources
Miscellaneous